sales@intentmarketresearch.com
+1 463-583-2713
As per Intent Market Research, the Blood Processing Devices & Consumables Market was valued at USD 42.4 billion in 2023 and will surpass USD 69.8 billion by 2030; growing at a CAGR of 7.4% during 2024 - 2030.
The blood processing devices and consumables market is an essential segment of the healthcare industry, driven by the rising demand for blood-related medical treatments and diagnostic procedures. This market encompasses a wide range of products designed to facilitate the collection, processing, and storage of blood and blood components. The increasing prevalence of chronic diseases, advancements in medical technology, and the growing number of surgical procedures have significantly contributed to the growth of this market. Additionally, the market is fueled by the rising demand for blood transfusion services, especially in hospitals and clinics, as well as the need for diagnostic laboratories that rely on blood tests for accurate diagnosis and treatment.
As healthcare systems evolve and the importance of blood-related treatments continues to grow, the blood processing devices and consumables market is expected to expand rapidly. Key drivers such as rising geriatric populations, growing healthcare awareness, and advancements in blood management systems will likely propel market growth. With innovations in blood processing technology, such as automated blood collection devices and advanced blood storage solutions, the market is positioned for continued expansion. The market is segmented into products (devices and consumables) and end-users (hospitals, diagnostic laboratories, and others), each playing a crucial role in the overall blood processing process.
The devices segment holds the largest share in the blood processing devices and consumables market, owing to the growing demand for advanced blood processing technologies across healthcare settings. Blood processing devices include a wide range of equipment used in blood collection, separation, storage, and transfusion processes. As the need for blood transfusions rises globally, hospitals and clinics are increasingly adopting automated and advanced devices to improve the efficiency and safety of blood processing. These devices enhance the accuracy of blood separation, minimize the risk of contamination, and ensure the optimal preservation of blood components.
Technological advancements in blood processing devices, such as continuous flow separation systems and blood bag systems with integrated monitoring functions, are further driving the market's growth. These innovations improve the safety and reliability of blood collection and transfusion processes, making them crucial for healthcare providers. Additionally, the growing trend of point-of-care testing and the shift toward automated blood collection methods in hospitals and diagnostic laboratories are boosting the demand for sophisticated blood processing devices. As hospitals and healthcare centers look to improve patient outcomes and reduce manual intervention, the adoption of these devices is expected to continue growing, solidifying their position as the largest segment in the market.
The consumables segment is the fastest growing in the blood processing devices and consumables market, driven by the increasing volume of blood collections, testing, and transfusions. Blood processing consumables include a variety of products such as blood bags, filters, needles, tubes, and reagents that are integral to the blood collection and processing process. With the rise in the number of surgical procedures, medical emergencies, and diagnostic testing, the need for consumables has surged, making them a key component of the market's growth.
As the healthcare industry increasingly focuses on blood safety, the demand for high-quality and disposable blood processing consumables continues to rise. The consumables used in blood collection and testing procedures are critical for preventing contamination and ensuring the integrity of blood samples. The increasing number of diagnostic tests performed, as well as the rising prevalence of chronic diseases requiring regular blood testing, is driving the growth of this segment. Furthermore, the trend toward disposable, single-use consumables for improved patient safety is encouraging hospitals and diagnostic laboratories to purchase these products in larger quantities. This shift is expected to propel the consumables segment as the fastest growing area of the blood processing market in the coming years.
The hospitals and clinics segment is the largest end-user of blood processing devices and consumables, driven by the significant volume of blood transfusions and other medical treatments involving blood products. Hospitals and clinics are the primary settings where blood collection, testing, and transfusions are carried out, making them a major consumer of blood processing products. The increasing number of patients requiring blood transfusions due to surgeries, trauma, cancer treatments, and chronic diseases has boosted the demand for blood processing devices and consumables in these healthcare facilities.
Moreover, hospitals are also incorporating advanced blood processing technologies to improve the efficiency of their operations and ensure patient safety. The adoption of automated blood processing devices, along with high-quality consumables, has become a standard practice in many hospitals and clinics to enhance the safety and effectiveness of blood transfusion procedures. As the global population ages and the number of surgical and emergency medical procedures increases, the demand for blood processing products in hospitals and clinics is expected to remain strong, securing their position as the largest end-user segment in the market.
North America is the leading region in the blood processing devices and consumables market, owing to its advanced healthcare infrastructure, high healthcare spending, and significant technological advancements in the medical sector. The United States, in particular, is a key market for blood processing products, with a large number of hospitals, diagnostic laboratories, and blood banks requiring advanced devices and consumables for blood collection, separation, and transfusion processes. The high prevalence of chronic diseases, along with an aging population, has further driven the demand for blood products and related technologies.
In addition to the strong demand for blood processing devices and consumables, North America benefits from continuous innovations in healthcare technologies. The region’s healthcare systems are at the forefront of adopting new blood management systems, automated processing devices, and safety-enhancing consumables. Furthermore, the regulatory environment in North America ensures that blood products and equipment meet the highest safety and quality standards, which is critical for the growth of the market. As North America continues to invest in healthcare advancements and blood management technologies, the region is expected to maintain its leadership in the global blood processing market.
The blood processing devices and consumables market is highly competitive, with several key players dominating the global market. Leading companies in this space include Thermo Fisher Scientific, Haemonetics Corporation, Baxter International Inc., Medtronic, and Stryker Corporation. These companies are continually innovating and expanding their product offerings to meet the growing demand for blood processing technologies. Product innovations, such as automated blood processing devices, as well as the development of disposable and safer consumables, are key strategies being employed to enhance market share.
In addition to product innovation, companies are focusing on strategic partnerships, acquisitions, and mergers to strengthen their presence in the global market. The emphasis on regulatory compliance, as well as the expansion of distribution networks, particularly in emerging markets, is shaping the competitive landscape. As the demand for blood-related treatments and diagnostics continues to grow, the competitive dynamics in the blood processing market are expected to become even more intense, with companies striving to differentiate themselves through technology, product quality, and customer service.
Report Features |
Description |
Market Size (2023) |
USD 42.4 billion |
Forecasted Value (2030) |
USD 69.8 billion |
CAGR (2024 – 2030) |
7.4% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Blood Processing Devices & Consumables Market By Product (Devices, Consumables), By End-use (Hospitals and Clinics, Diagnostic Laboratories) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
Biomerieux SA, Abbott, Bio-Rad Laboratories, Inc., BD, F. Hoffmann-La Roche Ltd, Danaher, Immucor, Inc., ThermoGenesis Holdings, Inc., Grifols, S.A., Terumo Corporation, Haemonetics Corporation, Macopharma |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Blood Processing Devices & Consumables Market, by Product (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. Devices |
4.1.1. Cell Processors |
4.1.2. Hematocrit Centrifuges |
4.1.3. Blood Bank Refrigerators |
4.1.4. Blood Bank Freezers |
4.1.5. Grouping Analyzers |
4.1.6. Warmers |
4.2. Consumables |
4.2.1. Blood Co-agulation Reagents |
4.2.2. Blood Grouping Reagents |
4.2.3. Hematology Reagents |
4.2.4. Blood Administration Sets |
4.2.5. Sedimentation Tubes |
4.2.6. Blood Bags |
4.2.7. Blood Collection Tubes |
4.2.8. Blood Collection Needles |
4.2.9. Blood Lancets |
4.2.10. Blood Filters |
4.2.11. Vials |
4.2.12. Slide Stainer |
4.2.13. Test Tube Racks |
4.2.14. Slides |
5. Blood Processing Devices & Consumables Market, by End-use (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Hospitals and Clinics |
5.2. Diagnostic Laboratories |
5.3. Others |
6. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Regional Overview |
6.2. North America |
6.2.1. Regional Trends & Growth Drivers |
6.2.2. Barriers & Challenges |
6.2.3. Opportunities |
6.2.4. Factor Impact Analysis |
6.2.5. Technology Trends |
6.2.6. North America Blood Processing Devices & Consumables Market, by Product |
6.2.7. North America Blood Processing Devices & Consumables Market, by End-use |
6.2.8. By Country |
6.2.8.1. US |
6.2.8.1.1. US Blood Processing Devices & Consumables Market, by Product |
6.2.8.1.2. US Blood Processing Devices & Consumables Market, by End-use |
6.2.8.2. Canada |
6.2.8.3. Mexico |
*Similar segmentation will be provided for each region and country |
6.3. Europe |
6.4. Asia-Pacific |
6.5. Latin America |
6.6. Middle East & Africa |
7. Competitive Landscape |
7.1. Overview of the Key Players |
7.2. Competitive Ecosystem |
7.2.1. Level of Fragmentation |
7.2.2. Market Consolidation |
7.2.3. Product Innovation |
7.3. Company Share Analysis |
7.4. Company Benchmarking Matrix |
7.4.1. Strategic Overview |
7.4.2. Product Innovations |
7.5. Start-up Ecosystem |
7.6. Strategic Competitive Insights/ Customer Imperatives |
7.7. ESG Matrix/ Sustainability Matrix |
7.8. Manufacturing Network |
7.8.1. Locations |
7.8.2. Supply Chain and Logistics |
7.8.3. Product Flexibility/Customization |
7.8.4. Digital Transformation and Connectivity |
7.8.5. Environmental and Regulatory Compliance |
7.9. Technology Readiness Level Matrix |
7.10. Technology Maturity Curve |
7.11. Buying Criteria |
8. Company Profiles |
8.1. Biomerieux SA |
8.1.1. Company Overview |
8.1.2. Company Financials |
8.1.3. Product/Service Portfolio |
8.1.4. Recent Developments |
8.1.5. IMR Analysis |
*Similar information will be provided for other companies |
8.2. Abbott |
8.3. Bio-Rad Laboratories, Inc. |
8.4. BD |
8.5. F. Hoffmann-La Roche Ltd |
8.6. Danaher. |
8.7. Immucor, Inc. |
8.8. ThermoGenesis Holdings, Inc. |
8.9. Grifols, S.A. |
8.10. Terumo Corporation |
8.11. Haemonetics Corporation |
8.12. Macopharma |
9. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Blood Processing Devices & Consumables Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Blood Processing Devices & Consumables Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the Blood Processing Devices & Consumables ecosystem. The primary research objectives included:
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Blood Processing Devices & Consumables Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.